FindTrial
Sign In

Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen

Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05971615
Acronym
GDS
Enrollment
90
Registered
2023-08-02
Start date
2020-01-15
Completion date
2020-12-18
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Brief summary

concordance between the lactate values on peripheral venous and arterial blood gases in all patients receiving an arterial sample on their arrival in the S.A.U.V.

Interventions

OTHERperipheral venous blood gases

peripheral venous blood gases

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* one of this condition in emergency unit : 1. acute respiratory distress 2. a suspicion of an acid-base disorder 3. a state of shock 4. Pathologies requiring monitoring of the respiratory system 5. Patient under NIV 6. Poisoning 7. Coma with a Glasgow score \< or equal to 8

Exclusion criteria

* Patient presenting another pathology supported in SAUV not requiring the realization of arterial blood gases * Patient aged \< 18 years * Pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frameDescription
lactates on peripheral venous and arterial blood gasesbaselinemmol/L

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026